NCT02881619View on ClinicalTrials.gov

Etodolac and Post-bleaching Sensitivity

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Medicaments Substances in Therapeutic Use
Interventions
DRUG

Etodolac

The patient will receive a single-dose of Etodolac (400 mg) one hour before the bleaching procedure.

DRUG

Placebo

The patient will receive a single-dose of placebo one hour before the bleaching procedure.

All Listed Sponsors
lead

Flavia Pardo Salata Nahsan

OTHER

NCT02881619 - Etodolac and Post-bleaching Sensitivity | Biotech Hunter | Biotech Hunter